急性冠脉综合征 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

Evaluation and Management of Nonculprit Lesions in STEMI
Effect of Pre-Hospital Crushed Prasugrel Tablets in Patients with STEMI Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial
New technologies for intensive prevention programs after myocardial infarction: rationale and design of the NET-IPP trial
BMI, Infarct Size, and Clinical Outcomes Following Primary PCI Patient-Level Analysis From 6 Randomized Trials
Early versus delayed invasive intervention in acute coronary syndromes
Imaging Coronary Anatomy and Reducing Myocardial Infarction
Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI
Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI
Heart Regeneration by Endogenous Stem Cells and Cardiomyocyte Proliferation: Controversy, Fallacy, and Progress
Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial

Clinical Trial

14 Oct 2020

JOURNAL：Circulation.

Effect of Pre-Hospital Crushed Prasugrel Tablets in Patients with STEMI Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial

GJ Vlachojannis , JM Wilschut , RF Vogel et al.

5923

Keywords: pre-hospital crushed prasugrel tablet vs. integral prasugrel tablet; oral platelet P2Y12 inhibiton

Full Text PDF